WHO's DOTS strategy

Proctor, Munro H.

doi:10.1016/s0140-6736(05)76126-2

Cited by 2 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Evidence suggests that most cases of active tuberculosis in elderly patients result from reactivation of latent infection. Each patient with recently analyzed TB illness, a particular treatment and care related suggestions should be conducted by specific team with the cooperation of other TB control program [38].…”

Section: Susceptibilitymentioning

confidence: 99%

Tuberculosis in geriatric patients

Mukhtar

Shaheen

Ashraf

et al. 2022

JCP

View full text Add to dashboard Cite

Tuberculosis is developing as a noteworthy medical problem in geriatrics. The indications are frequently non-particular and prompt postponed finding. Propelled infection state exhibit at the time of determination and regularly the analysis made at autopsy instead of amid life. Aging factors and presence of co-morbidities additionally modify the clinical picture. The doctors need a high record of doubt for the finding of tuberculosis in regards to geriatric patients give non-particular and misty side effects. Extraordinary consideration must be given to the observing for patients consistence with treatment, reactions of medications and medication associations.

show abstract

Section: Susceptibilitymentioning

confidence: 99%

Tuberculosis in geriatric patients

Mukhtar

Shaheen

Ashraf

et al. 2022

JCP

View full text Add to dashboard Cite

show abstract

Drugs For Children: The World Situation

Schaller

2000

Drug Information J

View full text Add to dashboard Cite

Much of the global burden of death and disease is concentrated in the world's developing countries. There is a core group of prophylactic and therapeutic substances capable of meeting the vast majority of health needs in these countries. Yet, the cost of purchasing pharmaceuticals can account for a high proportion of the total health expenditure of a developing nation. The World Health Organization initiated the Action Program of Essential Drugs to ensure worldwide access to affordable drugs of high quality as well as their rational and appropriate use. The world's children too, by right and by necessity, deserve access to essential drugs that have been tested and formulated for pediatric populations and accompanied by information for their appropriate use in children. The off-label use of drugs in children is common and additional problems of access to health care, and availability and cost of drugs, are even greater for children in poor countries. A first step in addressing these problems would be an international collaborative effort to compile a prioritized list of essential drugs for the world's children.

show abstract

WHO's DOTS strategy

Cited by 2 publications

References 1 publication

Tuberculosis in geriatric patients

Tuberculosis in geriatric patients

Drugs For Children: The World Situation

Contact Info

Product

Resources

About